首页> 外文期刊>Journal of the American College of Surgeons >Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma.
【24h】

Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma.

机译:孤立性肢体灌注治疗复发性黑色素瘤后肢体毒性与治疗效果之间的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The optimal toxic reaction of the normal tissues in perfused limbs after isolated limb perfusion (ILP) is unknown. Theoretically, more severe limb toxicity could reflect a concomitant increased toxic effect to the tumor and improved outcomes. We determined whether there is a relation between limb toxicity and treatment outcomes after ILP for recurrent limb melanoma. STUDY DESIGN: Among 252 patients with recurrent melanoma of the limbs, treatment outcomes in 192 patients (76%) with no or mild acute limb toxicity were compared with those in 60 (24%) with more severe reactions. Multivariate analysis was used to identify prognostic factors for complete response, limb recurrence-free interval, and survival. RESULTS: Among 112 patients with measurable disease, 65 patients (58%) had a complete response and 27 (42%) experienced a relapse in the perfused limb. For complete response, uninvolved regional lymph nodes (p = 0.0025) and ILP using tumor necrosis factor-alpha (p = 0.0076) appeared to be favorable prognostic factors in multivariate analysis. There was no evidence of a relation between limb toxicity and complete response either in univariate (p = 0.16) or multivariate analysis (p = 0.46). For limb recurrent-free interval, only the number of lesions was a significant prognostic factor (p = 0.047); limb toxicity was not (p = 0.095). In 140 patients with recurrent melanoma excised before or at the moment of ILP, independent prognostic factors for survival were gender, the number of positive nodes, and stage of disease. There was no relation between limb toxicity and survival in either univariate (p = 0.53) or multivariate analysis (p = 0.94). Forty-eight (34%) of the 140 patients had a relapse in the perfused limb. No prognostic factors for limb recurrent-free interval could be identified; limb toxicity was not related to relapse time in univariate or multivariate analyses (p = 0.16 and p = 0.14, respectively). CONCLUSIONS: More severe acute limb toxicity is not associated with improved outcomes. One should aim at grade II toxicity (slight erythema or edema, compatible with complete recovery) at the most to increase the therapeutic ratio of ILP.
机译:背景:孤立肢体灌注(ILP)后,灌注肢体正常组织的最佳毒性反应尚不清楚。从理论上讲,更严重的肢体毒性可能反映了对肿瘤的毒性作用增加和结果改善。我们确定了肢体黑色素瘤复发的ILP后肢体毒性与治疗效果之间是否存在关系。研究设计:在252例四肢复发性黑色素瘤患者中,将192例无或轻度急性肢体毒性的患者(76%)的治疗结果与60例(24%)严重反应的患者进行了比较。多因素分析用于确定完全缓解,无肢复发间隔和生存的预后因素。结果:在112例可测量疾病中,有65例(58%)完全缓解,有27例(42%)肢体复发。为了获得完整的反应,在多变量分析中,未参与的区域淋巴结转移(p = 0.0025)和使用肿瘤坏死因子-α的ILP(p = 0.0076)似乎是有利的预后因素。在单变量(p = 0.16)或多变量分析(p = 0.46)中,没有证据表明肢体毒性与完全缓解之间存在关联。对于肢体无复发间隔,只有病变数目是重要的预后因素(p = 0.047);没有肢体毒性(p = 0.095)。在ILP之前或之时切除的140例复发性黑色素瘤患者中,生存的独立预后因素是性别,阳性结节数和疾病阶段。在单变量(p = 0.53)或多变量分析(p = 0.94)中,肢体毒性与生存率之间没有关系。 140例患者中有48例(34%)的肢体复发。没有发现肢体无复发间隔的预后因素;在单因素或多因素分析中,肢体毒性与复发时间无关(分别为p = 0.16和p = 0.14)。结论:更严重的急性肢体毒性与改善预后无关。最多应针对II级毒性(轻度红斑或水肿,可完全恢复),以提高ILP的治疗率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号